Effect of oral N-acetyl cysteine on recurrent preterm labor following treatment for bacterial vaginosis

International Journal of Gynecology and Obstetrics

Volumn 104, Issue 1, 2009, Pages 44-48

  Shahin, Ahmed Y ^a   Hassanin, Ibrahim M A ^b   Ismail, Alaa M ^a   Kruessel, Jan S ^c   Hirchenhain, Jens ^c  

^a ASSIUT UNIVERSITY   (Egypt)

^b Sohag University   (Egypt)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Bacterial vaginosis; N acetyl cysteine; Preterm labor

Indexed keywords

ACETYLCYSTEINE; HYDROXYPROGESTERONE CAPROATE; METRONIDAZOLE; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; NAUSEA AND VOMITING; PATIENT COMPLIANCE; PREMATURE LABOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH DISEASE; TOCOLYSIS; TREATMENT OUTCOME; VAGINITIS;

EID: 57349093870     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2008.08.026     Document Type: Article

References (25)

1. Woods J.R. Reactive oxygen species and preterm premature rupture of membranes-a review. Placenta, 22 Suppl A (2001) S38-S44
2. Mercer B.M., Goldenberg R.L., Das A., Moawad A.H., Iams J.D., Meis P.J., et al. The preterm prediction study: a clinical risk assessment system. Am J Obstet Gynecol 174 6 (1996) 1885-1893
3. Flynn C.A., Helwig A.L., and Meurer L.N. Bacterial vaginosis in pregnancy and the risk of prematurity: a meta-analysis. J Fam Pract 48 11 (1999) 885-892
4. McGregor J.A., and French J.I. Bacterial vaginosis in pregnancy. Obstet Gynecol Surv 55 Suppl 1 (2000) S1-19
5. Hillier S.L., Nugent R.P., Eschenbach D.A., Krohn M.A., Gibbs R.S., Martin D.H., et al. Association between bacterial vaginosis and pre-term delivery of a low-birth-weight infant. New Engl J Med 333 26 (1995) 1737-1742
6. Swadpanich U., Lumbiganon P., Prasertcharoensook W., and Laopaiboon M. Antenatal lower genital tract infection screening and treatment programs for preventing preterm delivery. Cochrane Database Syst Rev 16 2 (2008) CD006178
7. Darwish A., Elnshar E.M., Hamadeh S.M., and Makarem M.H. Treatment options for bacterial vaginosis in patients at high risk of preterm labor and premature rupture of membranes. J Obstet Gynaecol Res. 33 6 (2007) 781-787
8. Espinoza J., Erez O., and Romero R. Preconceptional antibiotic treatment to prevent preterm birth in women with a previous preterm delivery. Am J Obstet Gynecol 194 3 (2006) 630-637
9. Hotchkiss R.S., and Karl I.E. The pathophysiology and treatment of sepsis. N Engl J Med 348 2 (2003) 138-150
10. Wentzel P., Thunberg L., and Eriksson U.J. Teratogenic effect of diabetic serum is prevented by supplementation of superoxide dismutase and N-acetylcysteine in rat embryo culture. Diabetologia 40 1 (1997) 7-14
11. De Vries N., and De Flora S. N-acetyl-l-cysteine. J Cell Biochem (1993) 270-277 Suppl 17F
12. Borgström L., Kågedal B., and Paulsen O. Pharmacokinetics of N-acetylcysteine in man. Eur J Clin Pharmacol 31 2 (1986) 217-222
13. Kelly G.S. Clinical applications of N-acetylcysteine. Altern Med Rev 3 2 (1998) 114-127
14. Amsel R., Totten P.A., Spiegel C.A., Chen K.C., Eschenbach D., and Holmes K.K. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiological associations. Am J Med 74 1 (1983) 14-22
15. Hauth J.C., Goldenberg R.L., Andrews W.W., DuBard M.B., and Copper R.L. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med 333 26 (1995) 1732-1736
16. Riggs B.S., Bronstein A.C., Kulig K., Archer P.G., and Rumack B.H. Acute acetaminophen overdose during pregnancy. Obstet Gynecol 74 2 (1989) 247-253
17. Roes E.M., Raijmakers M.T., Boo T.M., Zusterzeel P.L., Merkus H.M., Peters W.H., et al. Oral N-acetylcysteine administration does not stabilise the process of established severe preeclampsia. Eur J Obstet Gyn Reprod Biol 127 1 (2006) 61-67
18. Buhimschi I.A., Buhimschi C.S., and Weiner C.P. Protective effect of N-acetylcysteine against fetal death and preterm labor induced by maternal inflammation. Am J Obstet Gynecol 188 1 (2003) 203-208
19. Yokoo T., and Kitamura M. Dual regulation of IL-1 beta-mediated matrix metalloproteinase-9 expression in mesangial cells by NF-kappa B and AP-1. Am J Physiol 270 1 pt 2 (1996) F123-F130
20. Young A., Thomson A.J., Ledingham M., Jordan F., Greer I.A., and Norman J.E. Immunolocalization of proinflammatory cytokines in myometrium, cervix, and fetal membranes during human parturition at term. Biol Reprod 66 2 (2002) 445-449
21. Beloosesky R., Gayle D.A., Amidi F., Nunez S.E., Babu J., Desai M., et al. N-acetyl-cysteine suppresses amniotic fluid and placenta inflammatory cytokine responses to lipopolysaccharide in rats. Am J Obstet Gynecol 194 1 (2006) 268-273
22. Allport V.C., Pieber D., Slater D.M., Newton R., White J.O., and Bennett P.R. Human labour is associated with nuclear factor-kappaB activity which mediates cyclo-oxygenase-2 expression and is involved with the 'functional progesterone withdrawal'. Mol Hum Reprod 7 6 (2001) 581-586
23. Lappas M., Permezel M., and Rice G. N-Acetyl-cysteine inhibits phospholipid metabolism, proinflammatory cytokine release, protease activity, and nuclear factor kB deoxyribonucleic acid-binding activity in human fetal membranes in vitro. J Clin Endocrinol Metab 88 4 (2003) 1723-1729
24. Amin A.F. N-Acetyl Cysteine (NAC): A possible option in the treatment of unexplained recurrent pregnancy loss. Fertil Steril 83 5 (2005) S8 Suppl 1
25. Ornaghi F., Ferrini S., Prati M., and Giavini E. The protective effects of N-acetyl-L-cysteine against methyl mercury embryotoxicity in mice. Fundam Appl Toxicol. 20 4 (1993) 437-445